A practical overview of what the path from "I heard the best option might be in the U.S." to actually being evaluated by a U.S. center really looks like, and where it commonly gets stuck.
The single biggest factor in whether a U.S. trial search succeeds is how specific the starting diagnosis is. A confirmed genetic subtype, staging information, or detailed specialist notes narrow the search dramatically compared to a general condition name. If your diagnosis is still unclear, that's not a dead end — it just changes what you're looking for, from a specific trial to a specialized diagnostic program.
Public registries such as ClinicalTrials.gov list trials that are actively enrolling and are open to anyone to search directly. The practical difficulty most international patients and families run into isn't finding listings — it's determining which listings are a genuine match for their specific case, whether the trial is actually still enrolling, and whether the site accepts international patients at all. This is where an independent case review, rather than a keyword search, tends to save the most time.
Trial eligibility criteria are specific and unforgiving — age ranges, prior treatment history, exact genetic markers, and disease stage can all disqualify an otherwise promising-looking match. Verifying eligibility against your actual records, before you invest emotional and financial resources in pursuing an option, is worth doing carefully rather than quickly.
U.S. institutions typically require records in a specific format and, often, in English. Assembling a complete, well-organized application — rather than a folder of scattered documents — materially affects both the speed and quality of the response you get back.
If accepted, there's a second logistics layer: scheduling evaluations, coordinating around the receiving institution's calendar, arranging accommodation, and navigating medical visa documentation. None of this is clinical, but all of it affects whether the opportunity a patient qualifies for is actually usable in practice.
For longer courses of treatment, having a single consistent point of contact between the patient's family and the U.S. medical team — rather than starting over with communication each time — tends to reduce friction meaningfully over time.
This is the process RAINGAIA HEALTH's case review and coordination service is built around — independent verification at each step, and an honest answer if no genuine match exists, rather than proceeding with a poor fit. See the full breakdown on How It Works.
Yes — public registries like ClinicalTrials.gov list actively enrolling trials and are open to anyone. The challenge most international patients run into is translating a listing into a genuine, verified match for their specific diagnosis, confirming a center is actually accepting international patients, and organizing the application itself.
A confirmed diagnosis, or at minimum a clear working diagnosis with supporting records, makes case review far more effective. Undiagnosed or unclear cases can still be reviewed, but matching becomes about specialized diagnostic programs rather than a specific trial.
An upfront, non-refundable evaluation fee covers the initial case review and research. Exact amounts are confirmed before any payment is requested, and there is no obligation to proceed further after the initial review.